Pharmaceutical care path design of neuromyelitis optica spectrum disorders

Yao MENG,Ying ZHOU,Xiao-ling WANG,Ye WU,Yi-min CUI
DOI: https://doi.org/10.3969/j.issn.1672-3384.2017.01.009
2017-01-01
Abstract:Objective:Take neuromyelitis optica spectrum disorders for example to discuss the pharmaceutical care point of pediatric neurology disease, in order to improve the level and pertinence of pharmaceutical care. Methods:Corresponding pharmaceutical care points of acute treatment and remission treatment were analyzed. Pharmaceutical care process management and its adjustment according to the treatment strategy were designed, and standardized pharmaceutical care mode of clinical pharmacists was established.Results &Conclusion:Clinical pharmacists should improve pharmaceutical care level and to improve patients’ medication safety and compliance in order to gain a better treatment outcome.
What problem does this paper attempt to address?